Methodist Hospital Uses New Technology to Assist Urologists in
Early Diagnosis of Prostate Cancer
Methodist Hospital was the first in the U.S. to use the new Prostate MRI Program that assists urologists in the early diagnosis, treatment and staging of prostate cancer. The Prostate MRI Program is a non-invasive and painless medical procedure which creates detailed images of the prostate. The DynaCAD software automatically captures comprehensive clinical and diagnostic information that is important to the study.
With potentially 800,000 undetected TRUS Biopsy patients every year, MRI of the prostate helps the current standard of care. Magnetic technology has improved sensitivity and specificity in targeting areas of concern, allowing Urologists the ability to biopsy tumor suspicious regions in the prostate while still using the TRUS approach. There is a growing body of evidence supporting the effectiveness of MRI use, and Methodist Hospital is the only facility in San Antonio where this imaging is performed.
STATISTICS ON PROSTATE CANCER
Prostate cancer is the most common cancer, other than skin cancer, in American men. It’s the second leading cause of cancer death behind lung cancer. Approximately 1 in 6 men will be diagnosed with prostate cancer during his lifetime, and 1 in 35 will die.
The current standard of care includes a PSA (prostate-specific antigen) blood test which detects elevated PSA levels that can indicate prostate cancer or benign conditions and a DRE (Digital Rectal Exam). If a patient has elevated PSA levels and/or a suspicious lump found during the DRE, more tests may be required. Additional testing includes a TRUS-Guided Biopsy (transrectal ultrasound), which involves taking tissue samples from the prostate.
If you would like to find a doctor, please click on the tab above marked "Find a Physician"
You can call Methodist Healthcare HealthLine at 210-575-0355 or 1-800-333-7333, Monday – Friday, 8 a.m. – 5 p.m.
If you would like to inquire via email or contact a specific hospital or facility - CLICK HERE